Sign in for the best experience.
Explore new and notable updates in pulmonary vascular disease, including research into sex differences in outcomes of thrombectomy in patients with pulmonary embolism, the effects of exercise on alveolar dead space on patients with heart failure, and drug-drug interactions in pulmonary arterial hypertension (PAH) treatment. Review treatment recommendations for PAH shared during CHEST 2022, highlights from recent guideline updates from the European Society of Cardiology and European Respiratory Society, and available simulation sessions in 2023.
Sex Differences in Outcomes of Percutaneous Pulmonary Artery Thrombectomy in Patients With Pulmonary Embolism
Alveolar Dead Space Is Augmented During Exercise in Patients With Heart Failure With Preserved Ejection Fraction
Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension
Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension
Considerations When Selecting Patient-Reported Outcome Measures for Assessment of Health-Related Quality of Life in Patients With Pulmonary Hypertension: A Narrative Review
Thromboprophylaxis in Patients With COVID-19: A Brief Update to the CHEST Guideline and Expert Panel Report
This visual abstract investigates whether higher RV afterload is associated with greater risk of atrial fibrillation independent of left atrium and left ventricular remodeling.
VIEW THE DOWNLOADABLE PDF
READ THE RELATED ARTICLE »
CHEST Journal | Access even more pulmonary vascular disease research. READ THE JOURNAL »
Education Spotlight
Navigating PAH
Updates to PAH treatment guidelines
Simulation 2023
Advertisement
Take a deep dive into pulmonary hypertension diagnosis, management, and treatment with this curated list of relevant session recordings from CHEST 2022.
Some aspects of treatment for acute pulmonary embolism remain controversial. Review pros and cons of each in this course.
Review the latest update to CHEST’s guidelines for antithrombotic therapy and the prevention of thrombosis.
A new diagnosis of PAH can be confusing and frightening for patients. Help them better understand their disease and what to expect from treatment with resources covering the symptoms, therapies, and risk factors for PAH and busting common myths surrounding living with this disease. Plus, a comprehensive patient guide offers an in-depth look into every aspect of PAH, from diagnosis to treatment and long-term management.
DOWNLOADPAH MYTHS BUSTED
DOWNLOADPAH INFOGRAPHIC
DOWNLOADNAVIGATING PAH: PATIENT EDUCATION GUIDE
Real-world scenarios show complexity of initial and ongoing PAH treatment decisions More than a dozen treatment options are available for PAH. Review data on available therapies and management recommendations.
Key messages from the 2022 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension Read highlights from recent guideline updates from the European Society of Cardiology (ESC) and European Respiratory Society (ERS).
Restoration of RV function in PAH: Is it the holy grail to improve mortality and long-term outcomes? Read this review of recent research into the efficacy of techniques for improving mean pulmonary arterial pressure (mPAP) and the effects mPAP has on patient outcomes.
Emerging role of cardiopulmonary obstetric critical care Review strategies to decrease maternal morbidity and mortality rates among patients with preexisting or newly discovered heart and lung diseases.
Pulmonology Data Trends 2022 Get quick-hit overviews of the latest data on a wide variety of important topics in pulmonary medicine with infographics developed by leaders in the field.
Should therapeutic heparin be administered to acutely-ill hospitalized patients with COVID-19 Hear the authors of a recent article published in the journal CHEST debate the potential benefits and risks of administering therapeutic heparin to patients with COVID-19.
Enhance your expertise and get hands-on practice with important clinical skills at in-person simulation courses happening throughout 2023.
Review all aspects of the management of intermediate- and high-risk pulmonary embolism (PE) with three PE experts.
1.25 AMA PRA Category 1 Credits™
Stay up-to-date on the dramatic evolutions in pulmonary embolism care, including changes to risk stratification and advancements in reperfusion strategies.
If you’re not already a CHEST member, become one today for access to additional resources, discounts on educational activities, and networking opportunities.
JOIN NOW »